文献速递前列腺癌

多参数MRI对高强度聚焦超声治疗后残留或复发前列腺癌的诊断价值

Diagnostic value of multiparametric MRI in detecting residual or recurrent prostate cancer after high-intensity focused ultrasound.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2022-05-28

回顾性分析110例高强度聚焦超声(HIFU)治疗后随访活检患者的MRI,以活检为参考标准评估复发预测价值。MRI高度怀疑复发的敏感度低但特异度高,且为独立预测因子;初始活检阳性针数多者也增加复发风险。

要点

  • HIFU后MRI高度怀疑复发预测复发的敏感度低、特异度高。
  • MRI高度怀疑复发(OR=1.74)与初始活检阳性针数多(OR=1.25)为独立预测因子。
  • 初始活检阳性针数多的患者应避免HIFU,因复发风险增加。

核心结论

  • HIFU后MRI高度怀疑复发虽敏感度低,但因特异度高可能具有临床重要性,尤其需考虑活检采样误差的可能。
  • 诊断时癌症阳性针数多的患者应避免HIFU,因其复发风险增加。

研究设计与样本

  • 回顾性分析2019年8月至2021年4月间接受随访活检的110例连续患者的HIFU后MRI,由两名委员会认证的泌尿放射科医生以五点Likert量表评估复发可能性,以随访活检结果为参考标准。

主要发现

  • 在患者水平和区域水平分析中,HIFU后MRI的Likert量表预测复发的敏感度和特异度分别为0.37和0.97,以及0.42和0.87。
  • 两名MRI高度怀疑但活检阴性的患者需额外治疗以重获生化控制。
  • HIFU后MRI高度怀疑(比值比=1.74;p<0.01)和初始活检癌症阳性针数较多(比值比=1.25;p=0.03)是复发的独立预测因子。

关键数值与推荐

  • HIFU后MRI高度怀疑预测复发的比值比=1.74(p<0.01)。
  • 初始活检癌症阳性针数较多预测复发的比值比=1.25(p=0.03)。

临床怎么用

  • 作者认为HIFU后MRI高度怀疑复发因特异度高可能具有临床重要性,尤其需考虑活检采样误差的可能。
  • 作者建议诊断时癌症阳性针数多的患者应避免HIFU,因其复发风险增加。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the diagnostic performance of follow-up multiparametric MRI for prediction of recurrent prostate cancer after high-intensity focused ultrasound (HIFU), and to find other, if any, clinical or radiological predictors. MATERIALS AND METHODS: Post-HIFU MRIs of 110 consecutive patients who underwent follow-up biopsies between August 2019 and April 2021 were retrospectively analyzed and the likelihood of recurrence was assessed on a five-point Likert scale by two board-certified uroradiologists. Diagnostic performance of the Likert scale assigned to the post-HIFU MRI was assessed using the follow-up biopsy results as a reference standard. Among the clinical and radiological variables, predictors of the recurrence were examined through logistic regression. RESULTS: In per-patient and per-sector analyses, Likert scale on post-HIFU MRI showed a sensitivity and specificity of 0.37 and 0.97, and 0.42 and 0.87, respectively, in predicting recurrence. Two patients with high suspicion on MRI required additional treatment to regain biochemical control despite negative biopsies. High suspicion on post-HIFU MRI (odds ratio = 1.74; p < 0.01), and more cancer-positive cores on initial biopsy (odds ratio = 1.25; p = 0.03) were independent predictors of recurrence. CONCLUSION: Albeit with low sensitivity, high suspicion on post-HIFU MRI may be clinically important because of its high specificity, especially when considering the possibility of sampling error in biopsies. Patients with a high number of cancer-positive cores at diagnosis should avoid HIFU as they have an increased risk of recurrence.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Ahn H, Hwang SI, Kim TM, et al. Diagnostic value of multiparametric MRI in detecting residual or recurrent prostate cancer after high-intensity focused ultrasound. Prostate Cancer Prostatic Dis. 2022. PMID: 35643729. doi:10.1038/s41391-022-00531-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。